Fondation ILDYS, Site de Ty Yann
Brest, France
NCT Number: NCT06941597
Cardiovascular disease (CVD) is the leading cause of death in France for women and the second leading cause of death for men after cancer. They cause around 140,000 deaths every year, or almost 400 people every day throughout France. CVD also accounts for over a million hospital admissions a year, 160,000 of which are attributable to heart failure.
At present, cardiovascular rehabilitation centres mainly use exercise training methods based on sessions on cycloergometers and active walking (walking on a track and/or treadmill). Convinced of the added value of Orienteering, we have included it in our routine treatment as part of our Cardiac Rehabilitation programme, in addition to sessions on cycloergometers and active walking since 2021. As there is little literature on the subject in our population of interest, the aim of this study is to provide evidence of the relevance of orienteering in the cardiac rehabilitation programme.
We hypothesise that orienteering induces a similar cardiac response, amount of physical activity and perception of symptoms compared with an active walking session, while providing greater enjoyment of the activity.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Brest, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: once during the second and third week of cardiac rehabilitation
Average heart rate measured during the active walking session and the orienteering race.
Time frame: once during the second and third week of cardiac rehabilitation
The maximum heart rate (bpm) will be collected for each of the three sessions.
Time frame: once during the second and third week of cardiac rehabilitation
The effort intensity score will be collected for each of the 3 sessions on a Borg scale (0-10). The modified Borg scale, also known as the CR10, is a simplified version of the original scale. It comprises 11 levels of perceived effort, ranging from 0 (no effort) to 10 (maximum effort).
Time frame: once during the second and third week of cardiac rehabilitation
Physical activity performance will be measured for each session by the total number of steps taken during active walking and orienteering.
Time frame: once during the second and third week of cardiac rehabilitation
Physical activity performance will be measured for each session by the time spent in the different intensity levels (light, moderate, vigorous) (in minutes and as a percentage).
Time frame: once during the second and third week of cardiac rehabilitation
Physical activity performance will be measured for each session by the distance covered in kilometres.
Time frame: once during the second and third week of cardiac rehabilitation
Perceived motivation to carry out the activity using a Likert scale from 0 to 5. The Likert scale is a semantic scoring system, generally made up of 5 or 7 items, which is used in surveys to measure and evaluate perceptions, attitudes and opinions.
Time frame: once during the second and third week of cardiac rehabilitation
The feeling of pleasure for the three activity sessions will be measured on a Likert scale from 0 to 5. The Likert scale is a semantic rating system, generally composed of 5 or 7 items, which is used in surveys to measure and evaluate perceptions, attitudes and opinions.
Time frame: once during the second and third week of cardiac rehabilitation
The desire to continue physical activity between the three physical activities will be measured by a Likert scale from 0 to 5. The Likert scale is a semantic rating system, generally composed of 5 or 7 items, which is used in surveys to measure and evaluate perceptions, attitudes and opinions.
Time frame: once during the second and third week of cardiac rehabilitation
Changes in heart rate over the three sessions (recorded every 5 minutes for 50 minutes for each session)
Fondation Ildys
Other
Acronym: CAMCO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07252531
Cardiovascular Diseases, Cardiovascular Diseases (CVD)
Rotterdam, Netherlands
View Trial DetailsNCT07540598
Cardiac Surgery, Cardiovascular Diseases
Palembang, South Sumatra, Indonesia
View Trial DetailsNCT07430644
Cardiovascular Diseases, Cardiovascular Diseases (CVD)
Calgary, Alberta, Canada
View Trial DetailsNCT07335471
Brain Diseases, Bronchial Diseases
Suzhou, Anhui, China
View Trial Details